Venlafaxine is an oral antidepressant medicine that the ChEMBL database records as a small molecule with an approved indication of depressive disorder. ChEMBL gives its first approval as 1993 and its highest development phase as 4, which means it has reached the market, and the World Health Organization classification places it at ATC code N06AX16 in the nervous system group. Its adopted name carries the stem -faxine, which the United States Adopted Names programme defines as an antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake, and the name was adopted in 1989. ChEMBL flags a boxed warning for the drug and records it as an oral product. This entry records what the sources state and is not medical advice.
Facts
Classification
Approval Status Route of Administration First Approved / Isolated Year Sources
1. Venlafaxine (ChEMBL)
ChEMBL molecule record, first_approval
"first_approval": 1993
ChEMBL molecule record, max_phase
"max_phase": "4.0"
ChEMBL molecule record, oral flag
"oral": true
View the Source2. RxNav RxClass, National Library of Medicine: RxClass ATC classes of Venlafaxine
RxNav RxClass, National Library of MedicineRxClass ATC class of the drug (levels 1 to 4); ATC class derived from cited code N06AX (main group N)Quote, RxClass ATC class of the drug (levels 1 to 4); ATC class derived from cited code N06AX (main group N)
"classId": "N06AX", "className": "Other antidepressants", "classType": "ATC1-4"
View the Source WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index: the WHO ATC/DDD Index entries named Venlafaxine
WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD IndexATC/DDD Index entry; ATC class derived from cited code N06AX16 (main group N)Quote, ATC/DDD Index entry; ATC class derived from cited code N06AX16 (main group N)
N06AX16 venlafaxine
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.